-PTI NEW DELHI: Prices of over 50 essential drugs including those used for treatment of HIV infection, diabetes, anxiety disorders, bacterial infections, angina and acid reflux have been capped by the government, leading to a price cut in the range of 5 per cent to 44 per cent. The National Drug Pricing Regulator has also fixed the retail prices of 29 formulations. "NPPA has fixed/revised ceiling prices of 55 scheduled formulations of Schedule-I...
More »SEARCH RESULT
Total Matching Records found : 137
Not consulted on scrapping drug pricing agency: Chairman -Vidya Krishnan
-The Hindu New Delhi: Days after it was revealed that the Centre is likely to dismantle the National Pharmaceutical Pricing Agency (NPPA), its chairman said the decision was ‘rushed’ and the agency was not consulted. “There were two meetings and the NPPA was not a party to them. Both meetings were held at short notice. This has been a rushed decision. For any policy change, there needs to be consultation. I understand...
More »Cash Crunch In Marathwada Village: In year of good yield, currency ban hits crop prices -Parthasarathi Biswas
-The Indian Express The State Bank of India, Maharashtra Gramin Bank and Nanded District Cooperative Bank have branches in Malegaon. But only the SBI and Gramin Bank branches are dispensing cash. Malegaon (Nanded): The family of Pralhad Ingole, a farmer who owns about 6 acre of land, is struggling in the absence of cash. The lone ATM in their village of Malegaon in Nanded district, operated by the State Bank of...
More »Out of essentials list, prices of 100 drugs may increase by 10% -Sushmi Dey
-The Times of India NEW DELHI: Prices of around 100 medicines, including those for Alzheimer's, diabetes and hypertension, could rise by up to 10% after they were removed from the national list of essential medicines. Though the move is likely to impact consumers, it comes as a relief to drug makers reeling under stringent price regulation for over a year. Overruling a previous order by the drug price regulator, the Centre has...
More »A disaster in the making -A Rangarajan
-Frontline Medecins Sans Frontieres warns that the free or regional trade agreements that are being negotiated, which seek to strengthen current patent regimes, are a potential threat to the developing world’s access to life-saving drugs, which it sources mostly from India. WHEN NELSON MANDELA’S GOVERNMENT passed the Medicines and Related Substances Control Act in 1997 to make medicines more accessible to the poor, 39 big pharmaceutical companies filed law suits in...
More »
